Hemlibra 60mg/0.4ml Vial (1 Vial) – Emicizumab Hemophilia A Injection
Hemlibra 60mg/0.4ml vial contains emicizumab, an advanced treatment for hemophilia A that helps prevent bleeding episodes by mimicking factor VIII function.
- The description claims that emicizumab reduces the risk of spontaneous bleeding.
- The description claims that Hemlibra provides consistent protection and improved quality of life.
Variants (1)
- Default Title — 9029.30 JOD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
77%